Pain Relief Drug Shows Potential Anti-Cancer Benefits

Recent research suggests that ibuprofen, a common pain reliever, may have anti-cancer properties, particularly in reducing the risk of endometrial, bowel, breast, lung, and prostate cancers, by reducing inflammation and affecting cancer-related genes. However, experts caution against self-medicating due to potential side effects and emphasize lifestyle prevention strategies.